4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-028232
Global Head of R&D gave up 4,322 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Berger Dietmar Global Head of R&D | 2019-05-07 | Shares withheld for taxes | −4,322 | $33.46 | $144,614 | 85,678 | D |
Loading xslF345X03/doc4.xml…